Empowering a health tech company to diagnose disease onset faster and improve treatment pathways
A healthcare technology company specializing in Parkinson's disease treatment faced the challenge of securing FDA approval while optimizing costs for platform enhancement. Infosys provided a two-fold solution, establishing a POD with medical device engineers and healthcare domain consultants. They designed a digital biomarker platform, enabling continuous data collection, health data interpretation through AI/ML algorithms, and insights for researchers and clinicians. The benefits included faster FDA approval, a product engineering mindset through DevOps, and scalability for various neurological diseases. Infosys' agile approach revolutionized neuroscience research and patient care, ensuring the earliest possible detection.
